关注
Árpád Farkas
Árpád Farkas
Centre for Energy Research
在 energia.mta.hu 的电子邮件经过验证
标题
引用次数
引用次数
年份
Lung burden and deposition distribution of inhaled atmospheric urban ultrafine particles as the first step in their health risk assessment
I Salma, P Füri, Z Németh, I Balásházy, W Hofmann, Á Farkas
Atmospheric Environment 104, 39-49, 2015
922015
Detailed mathematical description of the geometry of airway bifurcations
CJ Hegedűs, I Balásházy, Á Farkas
Respiratory physiology & neurobiology 141 (1), 99-114, 2004
852004
Simulation of the effect of local obstructions and blockage on airflow and aerosol deposition in central human airways
A Farkas, I Balashazy
Journal of Aerosol Science 38 (8), 865-884, 2007
812007
Characterization of regional and local deposition of inhaled aerosol drugs in the respiratory system by computational fluid and particle dynamics methods
Á Farkas, I Balásházy, K Szőcs
Journal of aerosol medicine 19 (3), 329-343, 2006
812006
Quantification of particle deposition in asymmetrical tracheobronchial model geometry
Á Farkas, I Balásházy
Computers in Biology and Medicine 38 (4), 508-518, 2008
692008
Deposition distribution of the new coronavirus (SARS-CoV-2) in the human airways upon exposure to cough-generated droplets and aerosol particles
BG Madas, P Füri, Á Farkas, A Nagy, A Czitrovszky, I Balásházy, ...
Scientific reports 10 (1), 22430, 2020
592020
Three-dimensional model for aerosol transport and deposition in expanding and contracting alveoli
I Balásházy, W Hofmann, Á Farkas, BG Madas
Inhalation toxicology 20 (6), 611-621, 2008
572008
Significance of breath-hold time in dry powder aerosol drug therapy of COPD patients
A Horváth, I Balásházy, G Tomisa, Á Farkas
European Journal of Pharmaceutical Sciences 104, 145-149, 2017
552017
Aerodynamic properties and in silico deposition of isoniazid loaded chitosan/thiolated chitosan and hyaluronic acid hybrid nanoplex DPIs as a potential TB treatment
M Mukhtar, E Pallagi, I Csóka, E Benke, Á Farkas, M Zeeshan, K Burián, ...
International Journal of Biological Macromolecules 165, 3007-3019, 2020
372020
Aerodynamic properties and in silico deposition of meloxicam potassium incorporated in a carrier-free DPI pulmonary system
A Chvatal, Á Farkas, I Balásházy, P Szabó-Révész, R Ambrus
International Journal of Pharmaceutics 520 (1-2), 70-78, 2017
362017
Experimental and computational study of the effect of breath-actuated mechanism built in the NEXThaler® dry powder inhaler
Á Farkas, D Lewis, T Church, A Tweedie, F Mason, AE Haddrell, JP Reid, ...
International Journal of Pharmaceutics 533 (1), 225-235, 2017
332017
Non-linear relationship of cell hit and transformation probabilities in a low dose of inhaled radon progenies
I Balásházy, Á Farkas, BG Madas, W Hofmann
Journal of Radiological Protection 29 (2), 147, 2009
332009
Novel dry powder inhaler formulation containing antibiotic using combined technology to improve aerodynamic properties
R Ambrus, E Benke, Á Farkas, I Balásházy, P Szabó-Révész
European Journal of Pharmaceutical Sciences 123, 20-27, 2018
312018
Numerical simulation of emitted particle characteristics and airway deposition distribution of Symbicort® Turbuhaler® dry powder fixed combination aerosol drug
Á Farkas, Á Jókay, I Balásházy, P Füri, V Müller, G Tomisa, A Horváth
European Journal of pharmaceutical sciences 93, 371-379, 2016
312016
The effect of oral and nasal breathing on the deposition of inhaled particles in upper and tracheobronchial airways
F Lizal, J Elcner, J Jedelsky, M Maly, M Jicha, Á Farkas, M Belka, Z Rehak, ...
Journal of Aerosol Science 150, 105649, 2020
282020
Simulation of deposition and clearance of inhaled particles in central human airways
I Balashazy, A Farkas, I Szöke, W Hofmann, R Sturm
Radiation protection dosimetry 105 (1-4), 129-132, 2003
282003
Formulation and in vitro and in silico characterization of “nano-in-micro” dry powder inhalers containing meloxicam
P Party, C Bartos, Á Farkas, P Szabó-Révész, R Ambrus
Pharmaceutics 13 (2), 211, 2021
262021
In vitro and in silico (IVIS) flow characterization in an idealized human airway geometry using laser Doppler anemometry and computational fluid dynamics techniques
A Kerekes, A Nagy, M Veres, I Rigó, Á Farkas, A Czitrovszky
Measurement 90, 144-150, 2016
262016
Establishment of relationships between native and inhalation device specific spirometric parameters as a step towards patient tailored inhalation device selection
Á Farkas, A Szipőcs, A Horváth, I Horváth, G Gálffy, J Varga, K Galambos, ...
Respiratory Medicine 154, 133-140, 2019
252019
Development of an innovative, carrier-based dry powder inhalation formulation containing spray-dried meloxicam potassium to improve the in vitro and in silico aerodynamic …
E Benke, Á Farkas, P Szabó-Révész, R Ambrus
Pharmaceutics 12 (6), 535, 2020
242020
系统目前无法执行此操作,请稍后再试。
文章 1–20